Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms
Tariq I. Mughal, Thomas Lion, Omar Abdel-Wahab, Ruben Mesa, Robyn M. Scherber, Danilo Perrotti, Michael Mauro, Srdan Verstovsek, Giuseppe Saglio, Richard A. Van Etten, Robert Kralovics
Producción científica: Review article › revisión exhaustiva
Profundice en los temas de investigación de 'Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms'. En conjunto forman una huella única.